1. Home
  2. UNTY vs EOLS Comparison

UNTY vs EOLS Comparison

Compare UNTY & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

N/A

Current Price

$54.69

Market Cap

555.8M

Sector

Finance

ML Signal

N/A

Logo Evolus Inc.

EOLS

Evolus Inc.

N/A

Current Price

$7.76

Market Cap

529.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UNTY
EOLS
Founded
1991
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
555.8M
529.1M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
UNTY
EOLS
Price
$54.69
$7.76
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
★ $68.55
$15.00
AVG Volume (30 Days)
38.8K
★ 612.3K
Earning Date
10-20-2026
11-04-2026
Dividend Yield
★ 1.16%
N/A
EPS Growth
★ 39.66
1.23
EPS
★ 2.82
N/A
Revenue
N/A
★ $297,176,000.00
Revenue This Year
$6.21
$12.44
Revenue Next Year
$9.62
$17.37
P/E Ratio
$19.59
★ N/A
Revenue Growth
N/A
★ 11.61
52 Week Low
$44.34
$3.86
52 Week High
$62.50
$9.31

Technical Indicators

Market Signals
Indicator
UNTY
EOLS
Relative Strength Index (RSI) 37.16 47.04
Support Level $54.13 $7.59
Resistance Level $57.12 $8.47
Average True Range (ATR) 1.19 0.32
MACD -0.10 -0.03
Stochastic Oscillator 22.48 46.18

Price Performance

Historical Comparison
UNTY
EOLS

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: